Brudzinski sign is positive in
| Condition | Notes |
|---|---|
| Bacterial meningitis | Most common; sign present along with Kernig's sign and nuchal rigidity |
| Viral (aseptic) meningitis | Similar meningeal irritation |
| Tuberculous meningitis | Though classic signs may be less prominent |
| Fungal meningitis (e.g., Cryptococcus) | Especially in immunocompromised patients |
| Meningococcemia with meningitis | Kernig and Brudzinski signs may become positive |
| Subarachnoid hemorrhage (SAH) | Blood in subarachnoid space causes chemical meningeal irritation |
Fever + Nuchal rigidity + Headache — with Kernig's and Brudzinski's signs as hallmark clinical signs of meningeal irritation.
Lipoprotein metabolism
| Lipoprotein | Density | Major Lipid | Key Apolipoprotein | Origin |
|---|---|---|---|---|
| Chylomicron | Lowest | TG (~90%) | ApoB-48 | Intestine |
| VLDL | Very low | TG (~60%) | ApoB-100 | Liver |
| IDL | Intermediate | TG + Cholesterol | ApoB-100, ApoE | VLDL remnant |
| LDL | Low | Cholesterol (~70% of plasma cholesterol) | ApoB-100 | IDL remnant |
| HDL | Highest | Cholesterol ester | ApoA-I | Liver + Intestine |
| Apolipoprotein | Source | Lipoprotein | Function |
|---|---|---|---|
| ApoB-48 | Intestine | Chylomicrons | Structural; does NOT bind LDL receptor |
| ApoB-100 | Liver | VLDL, IDL, LDL | Structural; ligand for LDL receptor |
| ApoC-II | Liver/HDL | Chylomicrons, VLDL | Activates LPL |
| ApoC-III | Liver/HDL | Chylomicrons, VLDL | Inhibits LPL |
| ApoE | Liver/HDL | Chylomicron remnants, IDL | Ligand for hepatic remnant receptor and LDL receptor |
| ApoA-I | Liver + Intestine | HDL | Structural; activates LCAT; promotes ABCA1-mediated cholesterol efflux |
| ApoA-V | Liver | VLDL, chylomicrons | Facilitates LPL activity |


| Enzyme | Location | Substrate | Activated by | Role |
|---|---|---|---|---|
| LPL (lipoprotein lipase) | Capillary endothelium (adipose, muscle) | TG in chylomicrons + VLDL | ApoC-II | Releases FFAs to tissues |
| HL (hepatic lipase) | Hepatic sinusoidal endothelium | TG + phospholipids in IDL, HDL | — | IDL → LDL; HDL2 → HDL3 |
| LCAT | Plasma (HDL-bound) | Cholesterol on HDL | ApoA-I | Esterifies cholesterol in HDL |
| CETP | Plasma | CE (HDL) ↔ TG (VLDL) | — | Transfers CE from HDL to VLDL/LDL |
| MTP | ER (liver + intestine) | Lipid loading of ApoB | — | Assembles VLDL + chylomicrons |
| ACAT | Intracellular | Cholesterol | — | Stores excess cholesterol as esters |
| Defect | Result | Disorder |
|---|---|---|
| LPL or ApoC-II deficiency | Massive hypertriglyceridemia (chylomicronemia) | Type I hyperlipoproteinemia (familial chylomicronemia); pancreatitis risk |
| LDL receptor defect | Elevated LDL-C | Familial hypercholesterolemia (FH); premature ASCVD |
| PCSK9 gain of function | LDL receptor degraded → high LDL | Autosomal dominant hypercholesterolemia |
| ApoE absence/defect | Impaired clearance of remnants | Type III hyperlipoproteinemia (broad beta disease) |
| MTP defect | No VLDL/chylomicron assembly | Abetalipoproteinemia; TG accumulates in liver/intestine; low fat-soluble vitamins |
| LCAT deficiency | Impaired cholesterol esterification in HDL | Low HDL, corneal opacities, hemolytic anemia |